Terence Novak, chief operating officer, TEDOR Pharma shares insights into the market trends, obstacles, and future growth of CDMOs in an online feature at Contract Pharma. Novak targets infrastructure and manufacturing capacity challenges as being critical capabilities that need to be addressed to provide quality contract development and manufacturing organization (CDMO) services.

To read more, from the article Oral Solids Remain Robust: Exploring trends in the oral solid dosage manufacturing market with some of today’s leading contract service providers, visit Contract Pharma.

Contact Tedor Pharma

Start typing and press Enter to search